In the article published today by BioStock, the company's CEO Peter Egelberg comments on National Institutes of Health and the developments during the past autumn. The article (in Swedish) is available here.
HoloMonitor® enables real-time label-free and quantitative studies of adherent cells directly in the cell incubator. Compared to standard methods the HoloMonitor approach saves both time, …
